Report Detail

Request for Sample of this report

Pharma & Healthcare Global Prescription Weight Loss Pills Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

  • RnM4535693
    • |
  • 13 June, 2023
    • |
  • Global
    • |
  • 109 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Prescription Weight Loss Pills market size was valued at USD 1162.7 million in 2022 and is forecast to a readjusted size of USD 2259 million by 2029 with a CAGR of 10.0% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Health care professionals use the Body Mass Index (BMI), a measure of people weight in relation to height, to define overweight and obesity. People who have a BMI between 25 and 30 are considered to be overweight. Obesity is defined as having a BMI of 30 or greater. Are overweight, obese, or severely obese, which may increase risk of developing health problems. Obesity is a chronic disease and prescription medications to treat overweight and obesity work in different ways. Prescription weight loss medicines can help obese people lose weight. They are usually prescribed by a doctor when diet and exercise alone are not working. Each of these medicines works differently. People who use these medicines may not feel as hungry. Or they may feel full after eating only a small amount of food. Another type of weight-loss medicine makes it harder for your body to absorb fat. Prescription weight loss drugs can be helpful when used in combination with a low-calorie diet and regular physical activity.
This report is a detailed and comprehensive analysis for global Prescription Weight Loss Pills market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Prescription Weight Loss Pills market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Prescription Weight Loss Pills market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Prescription Weight Loss Pills market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Prescription Weight Loss Pills market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Prescription Weight Loss Pills
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Prescription Weight Loss Pills market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Currax Pharmaceuticals (Contrave), VIVUS (Qsymia), Novo Nordisk A/S, Rhythm Pharmaceuticals (Imcivree) and Eli Lilly and Company (TRICARE), etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Prescription Weight Loss Pills market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Oral Tablets
Oral Capsules
Injections
Market segment by Application
Hospital
Pharmacy
Major players covered
Currax Pharmaceuticals (Contrave)
VIVUS (Qsymia)
Novo Nordisk A/S
Rhythm Pharmaceuticals (Imcivree)
Eli Lilly and Company (TRICARE)
CHEPLAPHARM (Xenical)
Pfizer
Teva Pharmaceutical (Actavis)
Haleon Group (alli)
Sanofi (Adlyxin)
AstraZeneca (BYDUREON BCise)
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Prescription Weight Loss Pills product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Prescription Weight Loss Pills, with price, sales, revenue and global market share of Prescription Weight Loss Pills from 2018 to 2023.
Chapter 3, the Prescription Weight Loss Pills competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Prescription Weight Loss Pills breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Prescription Weight Loss Pills market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Prescription Weight Loss Pills.
Chapter 14 and 15, to describe Prescription Weight Loss Pills sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Prescription Weight Loss Pills
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Prescription Weight Loss Pills Consumption Value by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Oral Tablets
    • 1.3.3 Oral Capsules
    • 1.3.4 Injections
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Prescription Weight Loss Pills Consumption Value by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Hospital
    • 1.4.3 Pharmacy
  • 1.5 Global Prescription Weight Loss Pills Market Size & Forecast
    • 1.5.1 Global Prescription Weight Loss Pills Consumption Value (2018 & 2022 & 2029)
    • 1.5.2 Global Prescription Weight Loss Pills Sales Quantity (2018-2029)
    • 1.5.3 Global Prescription Weight Loss Pills Average Price (2018-2029)

2 Manufacturers Profiles

  • 2.1 Currax Pharmaceuticals (Contrave)
    • 2.1.1 Currax Pharmaceuticals (Contrave) Details
    • 2.1.2 Currax Pharmaceuticals (Contrave) Major Business
    • 2.1.3 Currax Pharmaceuticals (Contrave) Prescription Weight Loss Pills Product and Services
    • 2.1.4 Currax Pharmaceuticals (Contrave) Prescription Weight Loss Pills Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Currax Pharmaceuticals (Contrave) Recent Developments/Updates
  • 2.2 VIVUS (Qsymia)
    • 2.2.1 VIVUS (Qsymia) Details
    • 2.2.2 VIVUS (Qsymia) Major Business
    • 2.2.3 VIVUS (Qsymia) Prescription Weight Loss Pills Product and Services
    • 2.2.4 VIVUS (Qsymia) Prescription Weight Loss Pills Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 VIVUS (Qsymia) Recent Developments/Updates
  • 2.3 Novo Nordisk A/S
    • 2.3.1 Novo Nordisk A/S Details
    • 2.3.2 Novo Nordisk A/S Major Business
    • 2.3.3 Novo Nordisk A/S Prescription Weight Loss Pills Product and Services
    • 2.3.4 Novo Nordisk A/S Prescription Weight Loss Pills Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Novo Nordisk A/S Recent Developments/Updates
  • 2.4 Rhythm Pharmaceuticals (Imcivree)
    • 2.4.1 Rhythm Pharmaceuticals (Imcivree) Details
    • 2.4.2 Rhythm Pharmaceuticals (Imcivree) Major Business
    • 2.4.3 Rhythm Pharmaceuticals (Imcivree) Prescription Weight Loss Pills Product and Services
    • 2.4.4 Rhythm Pharmaceuticals (Imcivree) Prescription Weight Loss Pills Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Rhythm Pharmaceuticals (Imcivree) Recent Developments/Updates
  • 2.5 Eli Lilly and Company (TRICARE)
    • 2.5.1 Eli Lilly and Company (TRICARE) Details
    • 2.5.2 Eli Lilly and Company (TRICARE) Major Business
    • 2.5.3 Eli Lilly and Company (TRICARE) Prescription Weight Loss Pills Product and Services
    • 2.5.4 Eli Lilly and Company (TRICARE) Prescription Weight Loss Pills Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Eli Lilly and Company (TRICARE) Recent Developments/Updates
  • 2.6 CHEPLAPHARM (Xenical)
    • 2.6.1 CHEPLAPHARM (Xenical) Details
    • 2.6.2 CHEPLAPHARM (Xenical) Major Business
    • 2.6.3 CHEPLAPHARM (Xenical) Prescription Weight Loss Pills Product and Services
    • 2.6.4 CHEPLAPHARM (Xenical) Prescription Weight Loss Pills Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 CHEPLAPHARM (Xenical) Recent Developments/Updates
  • 2.7 Pfizer
    • 2.7.1 Pfizer Details
    • 2.7.2 Pfizer Major Business
    • 2.7.3 Pfizer Prescription Weight Loss Pills Product and Services
    • 2.7.4 Pfizer Prescription Weight Loss Pills Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Pfizer Recent Developments/Updates
  • 2.8 Teva Pharmaceutical (Actavis)
    • 2.8.1 Teva Pharmaceutical (Actavis) Details
    • 2.8.2 Teva Pharmaceutical (Actavis) Major Business
    • 2.8.3 Teva Pharmaceutical (Actavis) Prescription Weight Loss Pills Product and Services
    • 2.8.4 Teva Pharmaceutical (Actavis) Prescription Weight Loss Pills Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 Teva Pharmaceutical (Actavis) Recent Developments/Updates
  • 2.9 Haleon Group (alli)
    • 2.9.1 Haleon Group (alli) Details
    • 2.9.2 Haleon Group (alli) Major Business
    • 2.9.3 Haleon Group (alli) Prescription Weight Loss Pills Product and Services
    • 2.9.4 Haleon Group (alli) Prescription Weight Loss Pills Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Haleon Group (alli) Recent Developments/Updates
  • 2.10 Sanofi (Adlyxin)
    • 2.10.1 Sanofi (Adlyxin) Details
    • 2.10.2 Sanofi (Adlyxin) Major Business
    • 2.10.3 Sanofi (Adlyxin) Prescription Weight Loss Pills Product and Services
    • 2.10.4 Sanofi (Adlyxin) Prescription Weight Loss Pills Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Sanofi (Adlyxin) Recent Developments/Updates
  • 2.11 AstraZeneca (BYDUREON BCise)
    • 2.11.1 AstraZeneca (BYDUREON BCise) Details
    • 2.11.2 AstraZeneca (BYDUREON BCise) Major Business
    • 2.11.3 AstraZeneca (BYDUREON BCise) Prescription Weight Loss Pills Product and Services
    • 2.11.4 AstraZeneca (BYDUREON BCise) Prescription Weight Loss Pills Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 AstraZeneca (BYDUREON BCise) Recent Developments/Updates

3 Competitive Environment: Prescription Weight Loss Pills by Manufacturer

  • 3.1 Global Prescription Weight Loss Pills Sales Quantity by Manufacturer (2018-2023)
  • 3.2 Global Prescription Weight Loss Pills Revenue by Manufacturer (2018-2023)
  • 3.3 Global Prescription Weight Loss Pills Average Price by Manufacturer (2018-2023)
  • 3.4 Market Share Analysis (2022)
    • 3.4.1 Producer Shipments of Prescription Weight Loss Pills by Manufacturer Revenue ($MM) and Market Share (%): 2022
    • 3.4.2 Top 3 Prescription Weight Loss Pills Manufacturer Market Share in 2022
    • 3.4.2 Top 6 Prescription Weight Loss Pills Manufacturer Market Share in 2022
  • 3.5 Prescription Weight Loss Pills Market: Overall Company Footprint Analysis
    • 3.5.1 Prescription Weight Loss Pills Market: Region Footprint
    • 3.5.2 Prescription Weight Loss Pills Market: Company Product Type Footprint
    • 3.5.3 Prescription Weight Loss Pills Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Prescription Weight Loss Pills Market Size by Region
    • 4.1.1 Global Prescription Weight Loss Pills Sales Quantity by Region (2018-2029)
    • 4.1.2 Global Prescription Weight Loss Pills Consumption Value by Region (2018-2029)
    • 4.1.3 Global Prescription Weight Loss Pills Average Price by Region (2018-2029)
  • 4.2 North America Prescription Weight Loss Pills Consumption Value (2018-2029)
  • 4.3 Europe Prescription Weight Loss Pills Consumption Value (2018-2029)
  • 4.4 Asia-Pacific Prescription Weight Loss Pills Consumption Value (2018-2029)
  • 4.5 South America Prescription Weight Loss Pills Consumption Value (2018-2029)
  • 4.6 Middle East and Africa Prescription Weight Loss Pills Consumption Value (2018-2029)

5 Market Segment by Type

  • 5.1 Global Prescription Weight Loss Pills Sales Quantity by Type (2018-2029)
  • 5.2 Global Prescription Weight Loss Pills Consumption Value by Type (2018-2029)
  • 5.3 Global Prescription Weight Loss Pills Average Price by Type (2018-2029)

6 Market Segment by Application

  • 6.1 Global Prescription Weight Loss Pills Sales Quantity by Application (2018-2029)
  • 6.2 Global Prescription Weight Loss Pills Consumption Value by Application (2018-2029)
  • 6.3 Global Prescription Weight Loss Pills Average Price by Application (2018-2029)

7 North America

  • 7.1 North America Prescription Weight Loss Pills Sales Quantity by Type (2018-2029)
  • 7.2 North America Prescription Weight Loss Pills Sales Quantity by Application (2018-2029)
  • 7.3 North America Prescription Weight Loss Pills Market Size by Country
    • 7.3.1 North America Prescription Weight Loss Pills Sales Quantity by Country (2018-2029)
    • 7.3.2 North America Prescription Weight Loss Pills Consumption Value by Country (2018-2029)
    • 7.3.3 United States Market Size and Forecast (2018-2029)
    • 7.3.4 Canada Market Size and Forecast (2018-2029)
    • 7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

  • 8.1 Europe Prescription Weight Loss Pills Sales Quantity by Type (2018-2029)
  • 8.2 Europe Prescription Weight Loss Pills Sales Quantity by Application (2018-2029)
  • 8.3 Europe Prescription Weight Loss Pills Market Size by Country
    • 8.3.1 Europe Prescription Weight Loss Pills Sales Quantity by Country (2018-2029)
    • 8.3.2 Europe Prescription Weight Loss Pills Consumption Value by Country (2018-2029)
    • 8.3.3 Germany Market Size and Forecast (2018-2029)
    • 8.3.4 France Market Size and Forecast (2018-2029)
    • 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
    • 8.3.6 Russia Market Size and Forecast (2018-2029)
    • 8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

  • 9.1 Asia-Pacific Prescription Weight Loss Pills Sales Quantity by Type (2018-2029)
  • 9.2 Asia-Pacific Prescription Weight Loss Pills Sales Quantity by Application (2018-2029)
  • 9.3 Asia-Pacific Prescription Weight Loss Pills Market Size by Region
    • 9.3.1 Asia-Pacific Prescription Weight Loss Pills Sales Quantity by Region (2018-2029)
    • 9.3.2 Asia-Pacific Prescription Weight Loss Pills Consumption Value by Region (2018-2029)
    • 9.3.3 China Market Size and Forecast (2018-2029)
    • 9.3.4 Japan Market Size and Forecast (2018-2029)
    • 9.3.5 Korea Market Size and Forecast (2018-2029)
    • 9.3.6 India Market Size and Forecast (2018-2029)
    • 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
    • 9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

  • 10.1 South America Prescription Weight Loss Pills Sales Quantity by Type (2018-2029)
  • 10.2 South America Prescription Weight Loss Pills Sales Quantity by Application (2018-2029)
  • 10.3 South America Prescription Weight Loss Pills Market Size by Country
    • 10.3.1 South America Prescription Weight Loss Pills Sales Quantity by Country (2018-2029)
    • 10.3.2 South America Prescription Weight Loss Pills Consumption Value by Country (2018-2029)
    • 10.3.3 Brazil Market Size and Forecast (2018-2029)
    • 10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

  • 11.1 Middle East & Africa Prescription Weight Loss Pills Sales Quantity by Type (2018-2029)
  • 11.2 Middle East & Africa Prescription Weight Loss Pills Sales Quantity by Application (2018-2029)
  • 11.3 Middle East & Africa Prescription Weight Loss Pills Market Size by Country
    • 11.3.1 Middle East & Africa Prescription Weight Loss Pills Sales Quantity by Country (2018-2029)
    • 11.3.2 Middle East & Africa Prescription Weight Loss Pills Consumption Value by Country (2018-2029)
    • 11.3.3 Turkey Market Size and Forecast (2018-2029)
    • 11.3.4 Egypt Market Size and Forecast (2018-2029)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
    • 11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

  • 12.1 Prescription Weight Loss Pills Market Drivers
  • 12.2 Prescription Weight Loss Pills Market Restraints
  • 12.3 Prescription Weight Loss Pills Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry
  • 12.5 Influence of COVID-19 and Russia-Ukraine War
    • 12.5.1 Influence of COVID-19
    • 12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Prescription Weight Loss Pills and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Prescription Weight Loss Pills
  • 13.3 Prescription Weight Loss Pills Production Process
  • 13.4 Prescription Weight Loss Pills Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Prescription Weight Loss Pills Typical Distributors
  • 14.3 Prescription Weight Loss Pills Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Prescription Weight Loss Pills. Industry analysis & Market Report on Prescription Weight Loss Pills is a syndicated market report, published as Global Prescription Weight Loss Pills Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Prescription Weight Loss Pills market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,686.56
    		4,029.84
    		5,373.12
    		3,198.12
    		4,797.18
    		6,396.24
    		529,203.60
    		793,805.40
    		1,058,407.20
    		292,876.80
    		439,315.20
    		585,753.60
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo